ABSTRACT
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open helping early-career researchers promote themselves alongside their papers. Qingting Hu is first author on ‘Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion’, published in BIO. Qingting conducted the research described in this article while a Research Technician in Dr Nikki Cheng's lab at University of Kansas Medical Center, USA. She is now a Research Technician in the lab of Dr. Tonks Nicholas at Cold Spring Harbor Laboratory, USA, investigating downstream signaling mechanism of CCL2/CCR2 pathway in breast cancer progression.
Qingting Hu
What is your scientific background and the general focus of your lab?
I have a master's degree and an M.D. During the current study, I was working in Dr Cheng's laboratory as an exchange scholar from China. The major focus of Dr Cheng's laboratory is to study the molecular interactions between cancer cells and fibroblasts in breast cancer progression, and her lab has discovered that fibroblasts secrete high levels of the chemokine CCL2, and that CCL2 signals to breast cancer cells to promote breast cancer invasion through CCR2-dependent mechanisms. My research focus was to understand the molecular mechanisms of CCL2/CCR2 signaling in early stage breast cancer models.
How would you explain the main findings of your paper to non-scientific family and friends?
Our studies have discovered two molecules called ALDH1A1 and HTRA2 that are important for breast cancer growth and invasion. Expression and activity of these molecules are regulated by a factor called CCL2, which is normally important for immune responses.
“Our studies have discovered two molecules called ALDH1A1 and HTRA2 that are important for breast cancer growth and invasion.”
What are the potential implications of these results for your field of research?
Our detailed description on the molecular mechanisms of CCL2/CCR2 signaling in breast cancer cell growth and invasion can be used to identify biomarkers in order to better predict DCIS progression. These biomarkers could also be potential therapeutic targets to prevent or treat invasive breast cancer.
What has surprised you the most while conducting your research?
The most surprising results came in the beginning, when we treated two breast cancer cell lines (DCIS.com and SUM225) with recombinant CCL2, but only observed a responsive phenotype in DCIS.com cells. We were initially puzzled, but we reasoned that it was due to different expression levels of CCR2 receptors in those two cell lines. We confirmed this by flow cytometry analysis and that led to subsequent CCR2 overexpression and knockout/knockdown studies.
What, in your opinion, are some of the greatest achievements in your field and how has this influenced your research?
One advancement of the cancer research field is the development of 3D culture models to mimic tumor tissues. This provides a great advantage compared to traditional 2D cell culture, as it more closely mimics the structural features of breast tissues. That is why we used 3D culture models to characterize the mechanisms of CCL2/CCR2 signaling in breast cancer cells.
“One advancement of the cancer research field is the development of 3D culture models to mimic tumor tissues.”
What changes do you think could improve the professional lives of early-career scientists?
We early-career scientists often learn from making errors and mistakes. An encouraging mentor and good guidance are important. I was lucky to have such a mentor.
Sum225 culture in 3D.
What's next for you?
Apply for a Ph.D. program for further training in translational research.
Footnotes
Qingting Hu's contact details: Cold Spring Harbor Laboratory (One Bungtown Rd, Cold Spring Harbor, NY 11724, USA).
E-mail: qhu{at}cshl.edu
- © 2019. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Reference
Article Navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Cover article – A solution to prevent secondary flow in adherent cell cultures
Peter Szaraz and his colleagues show that, although secondary flow in small scale cultures can crucially affect cell phenotype and function, a simple modification of the classical round-shaped cell culture vessels can minimize the adverse effect of secondary flow.
Josh Currie, Tatiana Sandoval-Guzmán and their co-workers study dermal Prrx1 enhancer-positive cells, which are injury-responsive fibroblasts, and demonstrate that they readily migrate into the wound bed and amplify on average 16-fold beyond their uninjured numbers.
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with first authors Peter Szaraz, Josh Currie, Jeanette C. Perron, Louise Roberts and Qingting Hu.
Biology Open has strong credentials and publishing with us is easy and fast. BiO aims to provide rapid publication for scientifically sound observations and valid conclusions in developmental, cell, experimental and translational biology. Submit your paper here – you’ll be in good company!
Recent disease mechanism highlights in BiO – Bernhard Weber and his team find that mice carrying the human Y227N mutation in the endogenous Best1 gene reveal a pathologic phenotype in testis. This provides an in vivo tool to evaluate therapeutic efficacies aimed at restoring protein function.
Transfer to Biology Open
Did you know: if your submission to one of our sister journals, Development, Journal of Cell Science, Journal of Experimental Biology or Disease Models & Mechanisms, is unsuccessful, you can transfer your paper and any reviews directly to Biology Open! The majority of papers transferred with reviews are accepted for publication. Read here to find out more.
BiO partners with Publons!
Biology Open is pleased to announce a new partnership with Publons! This allows reviewers to easily track and verify every review by choosing to add the review to their Publons profile when completing the review submission form. Publons makes it simple for reviewers to showcase their peer review contributions in a format that can be included in job and funding applications (without breaking reviewer anonymity). Read the official announcement here!
preLights - Cross-kingdom recognition of bacterial small RNAs induces transgenerational pathogenic avoidance
Madhuja Samaddar highlights a preprint from Coleen Murphy’s lab, which uncovers how C. elegans pass on a learned avoidance of pathogenic Pseudomonas aeruginosa to four generations of its progeny!